• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HMGA2在子宫平滑肌瘤中的过表达表明其在该疾病发病机制中的普遍作用。

Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.

作者信息

Klemke Markus, Meyer Anke, Nezhad Maliheh Hashemi, Bartnitzke Sabine, Drieschner Norbert, Frantzen Christiane, Schmidt Ernst Heinrich, Belge Gazanfer, Bullerdiek Jörn

机构信息

Center for Human Genetics, University of Bremen, 28359 Bremen, Germany.

出版信息

Genes Chromosomes Cancer. 2009 Feb;48(2):171-8. doi: 10.1002/gcc.20627.

DOI:10.1002/gcc.20627
PMID:18980243
Abstract

An overexpression of HMGA2 is supposed to be a key event in the genesis of leiomyoma with chromosomal rearrangements affecting the region 12q14-15 targeting the HMGA2 gene, but gene expression data regarding differences between uterine leiomyomas with and those without 12q14-15 aberrations are insufficient. To address the question whether HMGA2 is only upregulated in the 12q14-15 subgroup, the expression of HMGA2 was analyzed in a comprehensive set of leiomyomas (n = 180) including tumors with 12q14-15 chromosomal aberrations (n = 13) and matching myometrial tissues (n = 51) by quantitative RT-PCR. The highest expression levels for HMGA2 were observed in tumors with rearrangements affecting the region 12q14-15, but although HMGA2 is expressed at lower levels in leiomyomas without such aberrations, the comparison between the expression in myomas and matching myometrial tissues indicates a general upregulation of HMGA2 regardless of the presence or absence of such chromosomal abnormalities. The significant (P < 0.05) overexpression of HMGA2 also in the group of fibroids without chromosomal aberrations of the 12q14-15 region suggests a general role of HMGA2 in the development of the disease.

摘要

HMGA2的过表达被认为是平滑肌瘤发生过程中的关键事件,其中染色体重排影响靶向HMGA2基因的12q14 - 15区域,但关于有和没有12q14 - 15畸变的子宫平滑肌瘤之间差异的基因表达数据不足。为了解决HMGA2是否仅在12q14 - 15亚组中上调的问题,通过定量RT - PCR分析了一组全面的平滑肌瘤(n = 180)中HMGA2的表达,包括有12q14 - 15染色体重排的肿瘤(n = 13)和匹配的肌层组织(n = 51)。在影响12q14 - 15区域的重排肿瘤中观察到HMGA2的最高表达水平,但是尽管HMGA2在没有此类畸变的平滑肌瘤中表达水平较低,但肌瘤与匹配的肌层组织之间的表达比较表明,无论是否存在此类染色体异常,HMGA2总体上均上调。在没有12q14 - 15区域染色体畸变的肌瘤组中HMGA2也有显著(P < 0.05)过表达,这表明HMGA2在该疾病发展中具有普遍作用。

相似文献

1
Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.HMGA2在子宫平滑肌瘤中的过表达表明其在该疾病发病机制中的普遍作用。
Genes Chromosomes Cancer. 2009 Feb;48(2):171-8. doi: 10.1002/gcc.20627.
2
6p21 rearrangements in uterine leiomyomas targeting HMGA1.子宫平滑肌瘤中靶向HMGA1的6p21重排
Cancer Genet Cytogenet. 2010 Dec;203(2):247-52. doi: 10.1016/j.cancergencyto.2010.08.005.
3
HMGA proteins regulate the expression of FGF2 in uterine fibroids.HMGA 蛋白调节子宫肌瘤中 FGF2 的表达。
Mol Hum Reprod. 2011 Feb;17(2):135-42. doi: 10.1093/molehr/gaq083. Epub 2010 Oct 6.
4
Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.HMGA2在子宫平滑肌瘤中的异常表达与TSC2肿瘤抑制基因功能丧失相关。
Cancer Res. 2002 Jul 1;62(13):3766-72.
5
Loss of let-7 binding sites resulting from truncations of the 3' untranslated region of HMGA2 mRNA in uterine leiomyomas.子宫平滑肌瘤中HMGA2 mRNA 3'非翻译区截断导致let-7结合位点缺失。
Cancer Genet Cytogenet. 2010 Jan 15;196(2):119-23. doi: 10.1016/j.cancergencyto.2009.09.021.
6
HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.HMGA2 与 p19Arf-TP53-CDKN1A 轴:子宫平滑肌瘤生长中的微妙平衡。
Genes Chromosomes Cancer. 2010 Aug;49(8):661-8. doi: 10.1002/gcc.20777.
7
HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.HMGA2在子宫平滑肌瘤和子宫肌层中的表达:定量分析与组织培养研究
Genes Chromosomes Cancer. 2003 Sep;38(1):68-79. doi: 10.1002/gcc.10240.
8
Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma.t(12;14)(q15;q24.1)子宫平滑肌瘤中嵌入HMGA2的新型人类转录本的鉴定与表征
Mutat Res. 2006 Dec 1;602(1-2):43-53. doi: 10.1016/j.mrfmmm.2006.07.007. Epub 2006 Oct 12.
9
Fusion of HMGA2 to COG5 in uterine leiomyoma.子宫平滑肌瘤中HMGA2与COG5的融合
Cancer Genet Cytogenet. 2010 Oct 1;202(1):11-6. doi: 10.1016/j.cancergencyto.2010.06.002.
10
Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.早期生长反应因子-1表达降低及其在子宫平滑肌瘤生长中的作用。
Cancer Res. 2004 Jul 1;64(13):4677-84. doi: 10.1158/0008-5472.CAN-03-0560.

引用本文的文献

1
The Roles of Non-Coding RNAs in the Pathogenesis of Uterine Fibroids.非编码RNA在子宫肌瘤发病机制中的作用
Cells. 2025 Aug 20;14(16):1290. doi: 10.3390/cells14161290.
2
UTERINE FIBROIDS.子宫肌瘤
Physiol Rev. 2025 Oct 1;105(4):1947-1988. doi: 10.1152/physrev.00010.2024. Epub 2025 Apr 11.
3
In Vitro Effect of Estrogen and Progesterone on Cytogenetic Profile of Uterine Leiomyomas.雌激素和孕激素对子宫平滑肌瘤细胞遗传学特征的体外影响
Int J Mol Sci. 2024 Dec 26;26(1):96. doi: 10.3390/ijms26010096.
4
Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.具有 RAD51B 融合的肉瘤与异质性表型相关。
Mod Pathol. 2024 Feb;37(2):100402. doi: 10.1016/j.modpat.2023.100402. Epub 2023 Dec 21.
5
Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids.子宫肌瘤可能的靶向治疗和预防的新方法。
Diseases. 2023 Nov 1;11(4):156. doi: 10.3390/diseases11040156.
6
A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.从遗传、表观遗传和细胞异质性的角度看子宫肌瘤的发生。
Int J Mol Sci. 2023 Mar 17;24(6):5752. doi: 10.3390/ijms24065752.
7
A transcriptome-wide association study of uterine fibroids to identify potential genetic markers and toxic chemicals.子宫纤维瘤的转录组关联研究,以鉴定潜在的遗传标记和有毒化学物质。
PLoS One. 2022 Sep 29;17(9):e0274879. doi: 10.1371/journal.pone.0274879. eCollection 2022.
8
A Possible Cause for the Differential Expression of a Subset of miRNAs in Mesenchymal Stem Cells Derived from Myometrium and Leiomyoma.肌源性和肌瘤源性间充质干细胞中一组 miRNA 差异表达的可能原因。
Genes (Basel). 2022 Jun 21;13(7):1106. doi: 10.3390/genes13071106.
9
Stem Cell Growth and Differentiation in Organ Culture: New Insights for Uterine Fibroid Treatment.器官培养中的干细胞生长与分化:子宫肌瘤治疗的新见解
Biomedicines. 2022 Jun 29;10(7):1542. doi: 10.3390/biomedicines10071542.
10
Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma.子宫平滑肌瘤原代单层细胞模型和器官型模型的建立。
Methods Protoc. 2022 Feb 6;5(1):16. doi: 10.3390/mps5010016.